Literature DB >> 21212126

Health ministers may call for appraisal of unlicensed cancer drug for eye treatment.

Nigel Hawkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21212126     DOI： 10.1136/bmj.d62

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Provider, patient and public benefits from a NICE appraisal of bevacizumab (Avastin).

Authors:  Catherine Rhodes; John Harris; John Sulston; Catherine Spanswick
Journal:  J Med Ethics       Date:  2011-09-24       Impact factor: 2.903
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.